Ipsen North America annonce un deuxième réapprovisionnement d’Increlex® (mecasermin [rDNA origin] Injection) aux Etats-Unis en 2014

This article or press release has no online content. Please download the associated documents for more information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021